Development Level

Tbio 7 | 10,625
Tchem 3 | 1,890

IMPC Term

abnormal lens morphology 1 | 73
abnormal retinal vasculature m... 1 | 15
immune system phenotype 1 | 17
preweaning lethality, incomple... 1 | 260

Disease

ovarian cancer 7 | 8,484
osteosarcoma 6 | 7,933
glioblastoma 5 | 5,572
lung cancer 5 | 4,466
Cancer 4 | 2,346
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
invasive ductal carcinoma 4 | 2,950
medulloblastoma, large-cell 4 | 6,234
Multiple myeloma 3 | 1,327
atypical teratoid / rhabdoid tumor 3 | 4,369
ductal carcinoma in situ 3 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
malignant mesothelioma 3 | 3,162
psoriasis 3 | 6,685
Bilirubin metabolic disorder 2 | 39
Breast cancer 2 | 3,094
Cataract 2 | 104
Congenital disorder of glycosylation 2 | 53
Epilepsy 2 | 346
Galactosemia 2 | 20
Hyperglycemia 2 | 120
Hyperinsulinism 2 | 63
Hypoglycemia 2 | 81
Metabolic syndrome X 2 | 155
Neutropenia 2 | 78
Obesity 2 | 616
adult high grade glioma 2 | 2,148
astrocytoma 2 | 1,493
colon cancer 2 | 1,475
diabetes mellitus 2 | 1,663
group 4 medulloblastoma 2 | 1,875
hepatocellular carcinoma 2 | 532
interstitial cystitis 2 | 2,299
lung adenocarcinoma 2 | 2,713
lung carcinoma 2 | 2,844
non-small cell lung cancer 2 | 2,798
pancreatic cancer 2 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
primary pancreatic ductal adenocarcinoma 2 | 1,271
Adenoma 1 | 165
Allergic hypersensitivity disease 1 | 123
Apraxia 1 | 25
Ataxia 1 | 15
Capillary hemangioma 1 | 11
Colonic Neoplasms 1 | 126
Congenital Disorder Of Glycosylation, Type IIID 1 | 1
Congenital disorder of glycosylation type 2D 1 | 1
Congenital hemolytic anemia 1 | 30
DESBUQUOIS DYSPLASIA 1 1 | 1
Degenerative polyarthritis 1 | 93
Desbuquois dysplasia 1 | 9
Desbuquois syndrome 1 | 2
Developmental Disabilities 1 | 20
Diabetes Mellitus, Non-Insulin-Dependent 1 | 157
Diarrhea 1 | 155
Diastrophic dysplasia 1 | 21
Drug allergy 1 | 36
Duodenitis 1 | 8
Dystonia 1 | 77
Exanthem 1 | 39
Glycogen storage disease 1 | 37
Gout 1 | 93
Hemangioma 1 | 35
Hepatitis D 1 | 10
Hyperuricemia 1 | 35
IGA Glomerulonephritis 1 | 454
Inborn Errors of Metabolism 1 | 16
Kernicterus 1 | 12
Lactic acidosis 1 | 42
Larsen syndrome 1 | 11
Liver carcinoma 1 | 217
Mammary Neoplasms 1 | 410
Mastitis 1 | 48
Microcephaly 1 | 149
Neonatal jaundice 1 | 15
Neoplastic Cell Transformation 1 | 81
Ovarian dysfunction 1 | 19
Pain disorder 1 | 13
Periventricular leukomalacia 1 | 6
Phenylketonuria 1 | 18
Premature ovarian failure 1 | 64
Renal Cell Carcinoma 1 | 199
Scoliosis 1 | 40
Seizures 1 | 95
Spondyloepiphyseal dysplasia with congenital joint dislocations 1 | 12
Urogenital tuberculosis 1 | 2
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 765
adrenocortical carcinoma 1 | 1,427
breast carcinoma 1 | 1,614
cystic fibrosis 1 | 1,665
medulloblastoma 1 | 1,524
nephrosclerosis 1 | 329
nervous system disorder 1 | 53
ovarian neoplasm 1 | 97
pancreatic carcinoma 1 | 567
pediatric high grade glioma 1 | 2,712
pituitary cancer 1 | 1,972
tuberculosis 1 | 1,557

Tissue

Blood and immune system 10 | 17,995
Cardiovascular System 10 | 17,958
Digestive Tract 10 | 18,473
Endocrine System 10 | 18,512
Female tissues 10 | 18,647
Nervous System 10 | 18,561
Skin and soft tissues 10 | 18,115
Urinary Tract 10 | 18,444
Liver and Pancreas 9 | 18,136
Respiratory system 9 | 17,484
Male tissues 8 | 17,969

Target Family

Enzyme 6 | 4,146
Kinase 2 | 634
Transporter 2 | 473

PathwayCommons: smpdb Pathway

Lactose Synthesis 10 | 10
Phenytoin (Antiarrhythmic) Act... 79 | 79
Lidocaine (Antiarrhythmic) Act... 61 | 61
Carvedilol Action Pathway 60 | 60
Labetalol Action Pathway 60 | 60
Muscle/Heart Contraction 60 | 60
Acebutolol Action Pathway 59 | 59
Alprenolol Action Pathway 59 | 59
Amiodarone Action Pathway 59 | 59
Amlodipine Action Pathway 59 | 59
Arbutamine Action Pathway 59 | 59
Atenolol Action Pathway 59 | 59
Betaxolol Action Pathway 59 | 59
Bevantolol Action Pathway 59 | 59
Bisoprolol Action Pathway 59 | 59
Bopindolol Action Pathway 59 | 59
Bupranolol Action Pathway 59 | 59
Carteolol Action Pathway 59 | 59
Diltiazem Action Pathway 59 | 59
Disopyramide Action Pathway 59 | 59
Dobutamine Action Pathway 59 | 59
Epinephrine Action Pathway 59 | 59
Esmolol Action Pathway 59 | 59
Felodipine Action Pathway 59 | 59
Flecainide Action Pathway 59 | 59
Fosphenytoin (Antiarrhythmic) ... 59 | 59
Ibutilide Action Pathway 59 | 59
Isoprenaline Action Pathway 59 | 59
Isradipine Action Pathway 59 | 59
Levobunolol Action Pathway 59 | 59
Metipranolol Action Pathway 59 | 59
Metoprolol Action Pathway 59 | 59
Mexiletine Action Pathway 59 | 59
Nadolol Action Pathway 59 | 59
Nebivolol Action Pathway 59 | 59
Nifedipine Action Pathway 59 | 59
Nimodipine Action Pathway 59 | 59
Nisoldipine Action Pathway 59 | 59
Nitrendipine Action Pathway 59 | 59
Oxprenolol Action Pathway 59 | 59
Penbutolol Action Pathway 59 | 59
Pindolol Action Pathway 59 | 59
Practolol Action Pathway 59 | 59
Procainamide (Antiarrhythmic) ... 59 | 59
Propranolol Action Pathway 59 | 59
Quinidine Action Pathway 59 | 59
Sotalol Action Pathway 59 | 59
Timolol Action Pathway 59 | 59
Tocainide Action Pathway 59 | 59
Verapamil Action Pathway 59 | 59
Azathioprine Action Pathway 47 | 47
Ibuprofen Action Pathway 47 | 47
Mercaptopurine Action Pathway 47 | 47
Thioguanine Action Pathway 47 | 47
Warburg Effect 45 | 45
Intracellular Signalling Throu... 38 | 38
AICA-Ribosiduria 37 | 37
Adenine phosphoribosyltransfer... 37 | 37
Adenosine Deaminase Deficiency 37 | 37
Adenylosuccinate Lyase Deficie... 37 | 37
Gout or Kelley-Seegmiller Synd... 37 | 37
Intracellular Signalling Throu... 37 | 37
Lesch-Nyhan Syndrome (LNS) 37 | 37
Mitochondrial DNA depletion sy... 37 | 37
Molybdenum Cofactor Deficiency 37 | 37
Myoadenylate deaminase deficie... 37 | 37
Purine Metabolism 37 | 37
Purine Nucleoside Phosphorylas... 37 | 37
Xanthine Dehydrogenase Deficie... 37 | 37
Xanthinuria type I 37 | 37
Xanthinuria type II 37 | 37
Fc Epsilon Receptor I Signalin... 36 | 36
Morphine Action Pathway 35 | 35
Retinol Metabolism 35 | 35
Vitamin A Deficiency 35 | 35
Celecoxib Action Pathway 34 | 34
Eplerenone Action Pathway 33 | 33
Spironolactone Action Pathway 33 | 33
Amiloride Action Pathway 32 | 32
Bendroflumethiazide Action Pat... 32 | 32
Blue diaper syndrome 32 | 32
Bumetanide Action Pathway 32 | 32
Chlorothiazide Action Pathway 32 | 32
Chlorthalidone Action Pathway 32 | 32
Cyclothiazide Action Pathway 32 | 32
Cystinuria 32 | 32
Ethacrynic Acid Action Pathway 32 | 32
Furosemide Action Pathway 32 | 32
Glucose Transporter Defect (SG... 32 | 32
Hartnup Disorder 32 | 32
Hydrochlorothiazide Action Pat... 32 | 32
Hydroflumethiazide Action Path... 32 | 32
Iminoglycinuria 32 | 32
Indapamide Action Pathway 32 | 32
Kidney Function 32 | 32
Lysinuric Protein Intolerance 32 | 32
Lysinuric protein intolerance ... 32 | 32
Methyclothiazide Action Pathwa... 32 | 32
Metolazone Action Pathway 32 | 32
Polythiazide Action Pathway 32 | 32
Quinethazone Action Pathway 32 | 32

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Soluble calcium-activated nucleotidase 1 CANT1 Tbio Enzyme -1.39200 25.3 175
Beta-1,4-galactosyltransferase 1 B4GALT1 Tbio Enzyme -2.28449 197.5 112
Solute carrier family 2, facilitated glucose transporter member 1 SLC2A1 Tchem Transporter -3.40027 2531.3 392
Nucleoside diphosphate kinase B NME1-NME2 Tbio Kinase -2.72044 972.8 83
Glucose-6-phosphatase G6PC Tchem Enzyme -2.93435 870.2 71
Alpha-lactalbumin LALBA Tbio Enzyme -3.22515 1681.2 235
UTP--glucose-1-phosphate uridylyltransferase UGP2 Tbio Enzyme -2.52916 337.9 131
UMP-CMP kinase CMPK1 Tbio Kinase -1.88023 87.6 203
UDP-galactose translocator SLC35A2 Tchem Transporter -2.94797 870.8 16
Galactose-1-phosphate uridylyltransferase GALT Tbio Enzyme -2.30637 208.9 205